Pre-market 03 Feb 2026 CGNX $39.76 (Cognex Corporation NASDAQ): Earnings and AI vision demand

CGNX stock trades pre-market at $39.76 as investors position ahead of Cognex Corporation’s Feb 11 earnings. Volume is active at 1,879,371 shares versus an average of 1,726,934. The machine vision leader faces mixed signals: strong institutional buying and high valuation with a PE of 61.17. We review fundamentals, technicals, analyst price targets and a model forecast to frame the AI-driven thesis for this NASDAQ-listed United States company.

CGNX stock: pre-market snapshot and catalysts

Price action is anchored at $39.76, with a day range of $38.23–$40.15. The 52-week range is $22.67–$49.76, showing recovery from last year’s lows.

Catalysts include the upcoming earnings on 2026-02-11, heavy institutional buying reported by Bank of New York Mellon, and continued demand for machine vision in AI-driven automation. See the market filing MarketBeat report for institutional moves.

CGNX analysis: fundamentals and valuation

Revenue-per-share is 5.79 and EPS (TTM) is 0.66, implying a trailing PE of 61.17. Profitability shows a net margin of 11.33% and ROE of 7.39%, which trail higher-growth peers in AI hardware.

Balance-sheet strength is clear: current ratio 3.96, cash per share 1.79, and low debt-to-equity 0.05. Price-to-sales is 6.71 and price-to-book is 4.46, signaling premium valuation that depends on growth re-acceleration.

CGNX technicals and Meyka grade

Technical indicators show momentum but caution. RSI is 59.29, ADX 25.84 indicating a trending market, and Bollinger middle band 36.79. Average volume is 1,726,934 and today’s volume sits at 1,879,371.

Meyka AI rates CGNX with a score out of 100: 71.88 (B+) — Suggestion: BUY. This grade factors S&P 500 and sector comparison, financial growth, key metrics, analyst consensus and forecasts. Grades are informational only and not financial advice.

CGNX forecast and analyst price targets

Analysts show mixed targets: consensus average target $45.64, with Barclays at $54.00 and Goldman Sachs at $50.00. The current market price implies a +14.81% upside to the average analyst target and +35.87% to Barclays’ target.

Meyka AI’s forecast model projects a yearly price of $30.27. Versus the current $39.76, that implies -23.88% downside. Forecasts are model-based projections and not guarantees. For full analyst notes and the Q4 report, see the Cognex earnings summary MarketBeat earnings report.

CGNX risks and opportunities for AI stocks strategy

Opportunity: Cognex is a core supplier for AI-enabled automation in automotive, electronics and logistics, supporting recurring software and vision product sales.

Risk: High valuation (PE 61.17) and slow EPS growth create sensitivity to cyclical capital spending. Inventory days are long at 166.83 days, which could pressure margins if demand slows.

Final Thoughts

Key takeaways for CGNX stock: Cognex (CGNX) trades at $39.76 pre-market on NASDAQ in the United States, with visible institutional accumulation and a scheduled earnings release on 2026-02-11. The company shows strong liquidity, low leverage, and healthy free cash flow per share 1.27, but carries a premium valuation at a PE of 61.17. Analyst targets average $45.64 (implied +14.81% upside), while Meyka AI’s model projects a yearly target of $30.27, implying -23.88% versus today’s price. Meyka’s B+ grade (score 71.88/100) balances sector strength and valuation. Investors using an AI stocks strategy should weigh Cognex’s exposure to industrial automation demand against the valuation risk ahead of earnings. For quick access to live metrics and updates visit our Meyka stock page for CGNX at https://meyka.ai/stocks/CGNX. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.